This clinical trial tests the effect of virtual reality psychosocial intervention (BMT-VR) in reducing distress in patients undergoing a bone marrow transplant. Patients hospitalized for a bone marrow transplant often experience physical and emotional symptoms and can have a negative effect on quality of life. Virtual reality is a technology that creates a computer generated experience that a person can interact with and generally requires a device with controllers or sensors. BMT-VR is self-guided and has several features to promote coping skills including education, supportive strategies and skill building. Providing BMT-VR to patients in the hospital for bone marrow transplant may improve coping skills and improve quality of life.
Additional locations may be listed on ClinicalTrials.gov for NCT05629676.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVES:
I. To examine the feasibility of bone marrow transplantation-virtual reality (BMT-VR) for patients with hematologic malignancies undergoing bone marrow transplant (BMT).
II. To determine the preliminary efficacy of BMT-VR for improving quality of life (QOL) and reducing psychological distress in patients undergoing BMT.
III. To explore the preliminary efficacy of BMT-VR on symptom burden, coping, and self-efficacy in patients undergoing BMT.
IV. To explore the effect of BMT-VR on healthcare utilization.
OUTLINE: Patients are randomized into 1 of 2 groups.
GROUP I (BMT-VR + Usual Care): Patients receive usual care by transplant team and undergo BMT-VR on study. Patients complete questionnaires throughout the trial.
Group II (Usual Care): Patients receive usual care by transplant team on study. Patients complete questionnaires throughout the trial.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorAreej El-Jawahri
